Encapsulated Living Cells For Diabetes: The Final Push?

 
• By John Davis

Lilly has linked up with US biotech Sigilon Therapeutics to develop encapsulated cell therapies for diabetes, a second "living therapeutics" approach to the condition to attract funding in the past six months.  

Injection
Injections may eventually be replaced by implanted living cells • Source: Shutterstock

More from Deals

More from Business